Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.

Hwang SH, Park S, Han K, Choi JY, Park YN, Park MS.

Abdom Radiol (NY). 2019 Jun 5. doi: 10.1007/s00261-019-02077-1. [Epub ahead of print]

PMID:
31165907
2.
3.

Prospective Intraindividual Comparison of Magnetic Resonance Imaging With Gadoxetic Acid and Extracellular Contrast for Diagnosis of Hepatocellular Carcinomas Using the Liver Imaging Reporting and Data System.

Min JH, Kim JM, Kim YK, Kang TW, Lee SJ, Choi GS, Choi SY, Ahn S.

Hepatology. 2018 Dec;68(6):2254-2266. doi: 10.1002/hep.30122. Epub 2018 Nov 12.

PMID:
30070365
4.

Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?

Zhang T, Huang ZX, Wei Y, Jiang HY, Chen J, Liu XJ, Cao LK, Duan T, He XP, Xia CC, Song B.

World J Gastroenterol. 2019 Feb 7;25(5):622-631. doi: 10.3748/wjg.v25.i5.622.

5.

LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.

Song JS, Choi EJ, Hwang SB, Hwang HP, Choi H.

Eur Radiol. 2019 Jan;29(1):401-410. doi: 10.1007/s00330-018-5559-z. Epub 2018 Jun 19.

PMID:
29922928
6.

Liver Imaging Reporting and Data System on CT and gadoxetic acid-enhanced MRI with diffusion-weighted imaging.

Cha DI, Jang KM, Kim SH, Kang TW, Song KD.

Eur Radiol. 2017 Oct;27(10):4394-4405. doi: 10.1007/s00330-017-4804-1. Epub 2017 Apr 3.

PMID:
28374073
7.

Interobserver and intermodality agreement of standardized algorithms for non-invasive diagnosis of hepatocellular carcinoma in high-risk patients: CEUS-LI-RADS versus MRI-LI-RADS.

Schellhaas B, Hammon M, Strobel D, Pfeifer L, Kielisch C, Goertz RS, Cavallaro A, Janka R, Neurath MF, Uder M, Seuss H.

Eur Radiol. 2018 Oct;28(10):4254-4264. doi: 10.1007/s00330-018-5379-1. Epub 2018 Apr 19.

PMID:
29675659
8.

Diagnostic accuracy of liver imaging reporting and data system (LI-RADS) v2014 for intrahepatic mass-forming cholangiocarcinomas in patients with chronic liver disease on gadoxetic acid-enhanced MRI.

Joo I, Lee JM, Lee SM, Lee JS, Park JY, Han JK.

J Magn Reson Imaging. 2016 Nov;44(5):1330-1338. doi: 10.1002/jmri.25287. Epub 2016 Apr 18.

PMID:
27087012
9.

Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.

Schellhaas B, Görtz RS, Pfeifer L, Kielisch C, Neurath MF, Strobel D.

Eur J Gastroenterol Hepatol. 2017 Sep;29(9):1036-1044. doi: 10.1097/MEG.0000000000000916.

PMID:
28562394
10.

Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.

Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, Matsuda M, Fujii H, Onishi H.

Magn Reson Med Sci. 2016;15(1):49-59. doi: 10.2463/mrms.2014-0149. Epub 2015 Jun 23.

11.

Gadoxetic acid-enhanced high temporal-resolution hepatic arterial-phase imaging with view-sharing technique: Impact on the LI-RADS category.

Goshima S, Noda Y, Kajita K, Kawai N, Koyasu H, Kawada H, Matsuo M, Bae KT.

Eur J Radiol. 2017 Sep;94:167-173. doi: 10.1016/j.ejrad.2017.06.023. Epub 2017 Jul 3.

PMID:
28709718
12.

Combined hepatocellular cholangiocarcinoma: LI-RADS v2017 categorisation for differential diagnosis and prognostication on gadoxetic acid-enhanced MR imaging.

Jeon SK, Joo I, Lee DH, Lee SM, Kang HJ, Lee KB, Lee JM.

Eur Radiol. 2019 Jan;29(1):373-382. doi: 10.1007/s00330-018-5605-x. Epub 2018 Jun 28.

PMID:
29955948
13.

Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas.

Ehman EC, Behr SC, Umetsu SE, Fidelman N, Yeh BM, Ferrell LD, Hope TA.

Abdom Radiol (NY). 2016 May;41(5):963-9. doi: 10.1007/s00261-015-0623-5.

14.

LI-RADS: Diagnostic Performance of Hepatobiliary Phase Hypointensity and Major Imaging Features of LR-3 and LR-4 Lesions Measuring 10-19 mm With Arterial Phase Hyperenhancement.

Vernuccio F, Cannella R, Meyer M, Choudhoury KR, Gonzáles F, Schwartz FR, Gupta RT, Bashir MR, Furlan A, Marin D.

AJR Am J Roentgenol. 2019 Aug;213(2):W57-W65. doi: 10.2214/AJR.18.20979. Epub 2019 Apr 30.

PMID:
31039012
15.

Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: Comparison with multiphasic multidetector computed tomography.

Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK.

J Magn Reson Imaging. 2017 Mar;45(3):731-740. doi: 10.1002/jmri.25406. Epub 2016 Jul 30.

PMID:
27474328
16.

Liver imaging reporting and data system (LI-RADS) v2018: comparison between computed tomography and gadoxetic acid-enhanced magnetic resonance imaging.

Nakao S, Tanabe M, Okada M, Furukawa M, Iida E, Miyoshi K, Matsunaga N, Ito K.

Jpn J Radiol. 2019 Jul 18. doi: 10.1007/s11604-019-00855-x. [Epub ahead of print]

PMID:
31321619
17.

Liver Imaging Reporting and Data System: Discordance Between Computed Tomography and Gadoxetate-Enhanced Magnetic Resonance Imaging for Detection of Hepatocellular Carcinoma Major Features.

Chernyak V, Flusberg M, Law A, Kobi M, Paroder V, Rozenblit AM.

J Comput Assist Tomogr. 2018 Jan/Feb;42(1):155-161. doi: 10.1097/RCT.0000000000000642.

PMID:
28806321
18.

Diagnostic accuracy of gadoxetic acid-enhanced MR for small hypervascular hepatocellular carcinoma and the concordance rate of Liver Imaging Reporting and Data System (LI-RADS).

Bae JS, Kim JH, Yu MH, Lee DH, Kim HC, Chung JW, Han JK.

PLoS One. 2017 May 30;12(5):e0178495. doi: 10.1371/journal.pone.0178495. eCollection 2017.

19.

Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.

An C, Rhee H, Han K, Choi JY, Park YN, Park MS, Kim MJ, Park S.

Eur Radiol. 2017 Jun;27(6):2610-2618. doi: 10.1007/s00330-016-4634-6. Epub 2016 Oct 21.

PMID:
27770230
20.

Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm.

Becker AS, Barth BK, Marquez PH, Donati OF, Ulbrich EJ, Karlo C, Reiner CS, Fischer MA.

Eur J Radiol. 2017 Jan;86:33-40. doi: 10.1016/j.ejrad.2016.11.004. Epub 2016 Nov 3.

PMID:
28027763

Supplemental Content

Support Center